Sponsor:
Cedars-Sinai Medical Center
Code:
NCT06392932
Conditions
Atrial Fibrillation Paroxysmal
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
QDOT Micro ablation catheter
ST SF ablation catheter
Brief summary:
Conditions
Atrial Fibrillation Paroxysmal
Study ID
NCT06392932
Start date
Oct 4, 2024
Status verified date
Oct, 2025
Completion date
Mar, 2027
Anticipated
Primary completion date
Oct, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
30 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: QDOT Arm
active comparator: ST SF Arm
Interventions
QDOT Micro ablation catheter
ST SF ablation catheter
Primary outcome measure
Central contacts
Tansy Aguilar
tansy.aguilar@cshs.orgLocations
Cedars-Sinai Smidt Heart Institute
Recruiting
Los Angeles, California, United States, 90048
Contacts
Sponsor
Cedars-Sinai Medical Center
Last update posted
Oct 28, 2025
Last verified
Oct, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Cedars-Sinai Medical Center on 2025-10-28.